Genes Highlight Who'll Benefit From Multiple Myeloma Treatment With Venclexta
WEDNESDAY, Dec. 4, 2024 -- Genetic tests can show which patients with the blood cancer multiple myeloma should respond to targeted therapy, a new study finds.
A special six-gene pattern can help predict who are more likely to respond well to...